Baidu
map

两会聚焦:"支持中医药事业传承发展",中医药界政协委员展开热议

2018-03-07 栗征 中国中医

国务院总理李克强在十三届全国人大一次会议开幕式上作政府工作报告,强调“支持中医药事业传承发展”,中医药界政协委员们就此展开热议——

国务院总理李克强在十三届全国人大一次会议开幕式上作政府工作报告,强调“支持中医药事业传承发展”,中医药界政协委员们就此展开热议——


“听了李克强总理的政府工作报告,我非常激动,这是一份高举旗帜、客观全面、成绩满满的报告。”中国中医科学院常务副院长黄璐琦委员在参加全国政协十三届一次会议医卫界小组会议时说,“报告中提出‘支持中医药事业传承发展’,更让我感到振奋。当前,中医药法已经颁布实施,应当依法大力推进中医药事业传承发展。”

坚持以人民为中心的发展思想,落实政府工作报告中“实施健康中国战略”“支持中医药事业传承发展”的要求,发挥中医药服务国家大局作用,这是中医药界政协委员们的共识

传承创新推动中医药振兴发展

“传承创新是推动中医药振兴发展的重要动力。”广东省中医院副院长卢传坚委员表示,中医药在漫长的历史长河中积累了丰富的经典名方和治疗手段,必须要继承好。“广东省中医院每天的门诊量达2万人次,说明患者认可的我们的疗效,而传承是提高疗效的重要前提。但继承传统的同时也要注重创新,用现代技术手段阐释中医药的科学内涵。”

党的十八大以来,中医药战略地位显着提升,法治建设取得突破性进展,服务能力、传承创新、国际影响长足进步。黄璐琦表示,下一阶段,要继续贯彻落实习近平总书记发展中医药的新思想新论断新要求,把中医药这一祖先留给我们的宝贵财富继承好、发展好、利用好。

北京康益德中西医结合肺科医院院长董瑞委员认为,中医药传承工作可分为理论传承、经验传承、流派传承等几个方面,在继承的基础上,还要重视理论、诊断、治疗、产业、人才培养等方面的发展。他表示:“国家在政策层面已经给予中医药传承发展很大支持,我们应该系统地把工作做扎实,让百姓享受实在可靠的优质中医药服务。”

服务大局发挥中医药独特优势

在政府工作报告中,“实施健康中国战略”是“提高保障和改善民生水平”的重要组成部分。《“健康中国2030”规划纲要》以提高人民健康水平为核心,牢固树立“大健康”理念,恰恰与中医药对健康的认识、维护促进健康的理念方法模式相吻合。

黑龙江省中医药科学院副院长王伟明委员认为,中医历来注重引导人们养成自主自律的健康生活方式。她特别强调要深度挖掘作息习惯、饮食规律、膳食搭配等中医药健康养生文化,帮助百姓树立具有中华民族特色的健康养生理念,提高全民健康素质,普及健康生活方式。

政府工作报告提出“大力实施乡村振兴战略”,中国中医科学院望京医院肛肠科主任安阿玥委员认为,应努力提升基层中医药服务能力,在乡村振兴战略中有位有为。他建议遴选一批简便验廉的中医治疗方法,在农村大力推广。“在保障百姓基本医疗方面,中医药应该占主导地位。”安阿玥说,“我是搞肛肠专业的,现在做一个PPH手术(吻合器痔环切术),费用过万。一个农民一年才挣多少钱,负担得起吗?然而我们中医有很好的、便宜的治疗方法,可以切实减轻农民的开销,避免因病致贫、因病返贫。”

创新驱动加强中医药科技成果转化

中国中医科学院西苑医院院长唐旭东委员除了关注政府工作报告中“实施健康中国战略”的相关内容外,还十分关注“加快建设创新型国家”的工作部署。“李克强总理强调深入实施创新驱动发展战略,提出加快创新成果转化应用,我很受鼓舞。”唐旭东表示,科研搞不好,中医药的传承发展必然面临困难,而科研恰恰是西苑医院的强项。在未来,西苑医院将继续做好“双轮驱动”战略:第一个轮子是保持并发挥中医药特色,建设“行业优秀品牌医院”;第二个轮子就是建设研究型中医医院,深化内涵建设,提高科技创新能力,加强高层次人才培养,为中医药振兴发展作出新的贡献。

“十二五”以来,中医药现代化发展水平不断提升,创新突破不断涌现。在黄璐琦看来,中医药事业要腾飞,必须要有健全的两翼,一翼是科学研究,一翼是科技普及。他同时强调,中医药科技成果转化要着眼于百姓需求。“应该大力推广中医药科研成果和适宜技术,推动科技成果转化为生产力,夯实中医药群众基础,把科技成果应用到实现现代化的伟大事业中。”

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (7)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1796849, encodeId=bc161e96849c1, content=<a href='/topic/show?id=768121555ad' target=_blank style='color:#2F92EE;'>#中医药界政协委员#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21555, encryptionId=768121555ad, topicName=中医药界政协委员)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=44a360, createdName=jklm09, createdTime=Tue Oct 30 16:45:00 CST 2018, time=2018-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1978078, encodeId=298219e80780e, content=<a href='/topic/show?id=5bca258e611' target=_blank style='color:#2F92EE;'>#传承发展#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=25876, encryptionId=5bca258e611, topicName=传承发展)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dc7a157, createdName=jinweidong, createdTime=Wed Apr 18 09:45:00 CST 2018, time=2018-04-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1675574, encodeId=ccce16e557408, content=<a href='/topic/show?id=8e7d258696c' target=_blank style='color:#2F92EE;'>#传承#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=25869, encryptionId=8e7d258696c, topicName=传承)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=85d827261473, createdName=lishizhe, createdTime=Sat Aug 04 19:45:00 CST 2018, time=2018-08-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1409400, encodeId=87f9140940092, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Fri Mar 09 10:45:00 CST 2018, time=2018-03-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1557974, encodeId=12c6155e974fe, content=<a href='/topic/show?id=9d09214948d' target=_blank style='color:#2F92EE;'>#中医药事业#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21494, encryptionId=9d09214948d, topicName=中医药事业)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=549e14938166, createdName=amy0555, createdTime=Fri Mar 09 10:45:00 CST 2018, time=2018-03-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1627066, encodeId=1ad2162e0665c, content=<a href='/topic/show?id=c9f65e45389' target=_blank style='color:#2F92EE;'>#政协委员#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=57453, encryptionId=c9f65e45389, topicName=政协委员)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bdbf21082352, createdName=dingxiaobo, createdTime=Fri Mar 09 10:45:00 CST 2018, time=2018-03-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=294016, encodeId=ab9f29401631, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/01/15/8213228fe923915543544ad3da7e1c64.jpg, createdBy=6bd82014262, createdName=秀红, createdTime=Thu Mar 08 05:56:26 CST 2018, time=2018-03-08, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1796849, encodeId=bc161e96849c1, content=<a href='/topic/show?id=768121555ad' target=_blank style='color:#2F92EE;'>#中医药界政协委员#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21555, encryptionId=768121555ad, topicName=中医药界政协委员)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=44a360, createdName=jklm09, createdTime=Tue Oct 30 16:45:00 CST 2018, time=2018-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1978078, encodeId=298219e80780e, content=<a href='/topic/show?id=5bca258e611' target=_blank style='color:#2F92EE;'>#传承发展#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=25876, encryptionId=5bca258e611, topicName=传承发展)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dc7a157, createdName=jinweidong, createdTime=Wed Apr 18 09:45:00 CST 2018, time=2018-04-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1675574, encodeId=ccce16e557408, content=<a href='/topic/show?id=8e7d258696c' target=_blank style='color:#2F92EE;'>#传承#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=25869, encryptionId=8e7d258696c, topicName=传承)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=85d827261473, createdName=lishizhe, createdTime=Sat Aug 04 19:45:00 CST 2018, time=2018-08-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1409400, encodeId=87f9140940092, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Fri Mar 09 10:45:00 CST 2018, time=2018-03-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1557974, encodeId=12c6155e974fe, content=<a href='/topic/show?id=9d09214948d' target=_blank style='color:#2F92EE;'>#中医药事业#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21494, encryptionId=9d09214948d, topicName=中医药事业)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=549e14938166, createdName=amy0555, createdTime=Fri Mar 09 10:45:00 CST 2018, time=2018-03-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1627066, encodeId=1ad2162e0665c, content=<a href='/topic/show?id=c9f65e45389' target=_blank style='color:#2F92EE;'>#政协委员#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=57453, encryptionId=c9f65e45389, topicName=政协委员)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bdbf21082352, createdName=dingxiaobo, createdTime=Fri Mar 09 10:45:00 CST 2018, time=2018-03-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=294016, encodeId=ab9f29401631, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/01/15/8213228fe923915543544ad3da7e1c64.jpg, createdBy=6bd82014262, createdName=秀红, createdTime=Thu Mar 08 05:56:26 CST 2018, time=2018-03-08, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1796849, encodeId=bc161e96849c1, content=<a href='/topic/show?id=768121555ad' target=_blank style='color:#2F92EE;'>#中医药界政协委员#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21555, encryptionId=768121555ad, topicName=中医药界政协委员)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=44a360, createdName=jklm09, createdTime=Tue Oct 30 16:45:00 CST 2018, time=2018-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1978078, encodeId=298219e80780e, content=<a href='/topic/show?id=5bca258e611' target=_blank style='color:#2F92EE;'>#传承发展#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=25876, encryptionId=5bca258e611, topicName=传承发展)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dc7a157, createdName=jinweidong, createdTime=Wed Apr 18 09:45:00 CST 2018, time=2018-04-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1675574, encodeId=ccce16e557408, content=<a href='/topic/show?id=8e7d258696c' target=_blank style='color:#2F92EE;'>#传承#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=25869, encryptionId=8e7d258696c, topicName=传承)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=85d827261473, createdName=lishizhe, createdTime=Sat Aug 04 19:45:00 CST 2018, time=2018-08-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1409400, encodeId=87f9140940092, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Fri Mar 09 10:45:00 CST 2018, time=2018-03-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1557974, encodeId=12c6155e974fe, content=<a href='/topic/show?id=9d09214948d' target=_blank style='color:#2F92EE;'>#中医药事业#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21494, encryptionId=9d09214948d, topicName=中医药事业)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=549e14938166, createdName=amy0555, createdTime=Fri Mar 09 10:45:00 CST 2018, time=2018-03-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1627066, encodeId=1ad2162e0665c, content=<a href='/topic/show?id=c9f65e45389' target=_blank style='color:#2F92EE;'>#政协委员#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=57453, encryptionId=c9f65e45389, topicName=政协委员)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bdbf21082352, createdName=dingxiaobo, createdTime=Fri Mar 09 10:45:00 CST 2018, time=2018-03-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=294016, encodeId=ab9f29401631, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/01/15/8213228fe923915543544ad3da7e1c64.jpg, createdBy=6bd82014262, createdName=秀红, createdTime=Thu Mar 08 05:56:26 CST 2018, time=2018-03-08, status=1, ipAttribution=)]
    2018-08-04 lishizhe
  4. [GetPortalCommentsPageByObjectIdResponse(id=1796849, encodeId=bc161e96849c1, content=<a href='/topic/show?id=768121555ad' target=_blank style='color:#2F92EE;'>#中医药界政协委员#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21555, encryptionId=768121555ad, topicName=中医药界政协委员)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=44a360, createdName=jklm09, createdTime=Tue Oct 30 16:45:00 CST 2018, time=2018-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1978078, encodeId=298219e80780e, content=<a href='/topic/show?id=5bca258e611' target=_blank style='color:#2F92EE;'>#传承发展#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=25876, encryptionId=5bca258e611, topicName=传承发展)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dc7a157, createdName=jinweidong, createdTime=Wed Apr 18 09:45:00 CST 2018, time=2018-04-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1675574, encodeId=ccce16e557408, content=<a href='/topic/show?id=8e7d258696c' target=_blank style='color:#2F92EE;'>#传承#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=25869, encryptionId=8e7d258696c, topicName=传承)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=85d827261473, createdName=lishizhe, createdTime=Sat Aug 04 19:45:00 CST 2018, time=2018-08-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1409400, encodeId=87f9140940092, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Fri Mar 09 10:45:00 CST 2018, time=2018-03-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1557974, encodeId=12c6155e974fe, content=<a href='/topic/show?id=9d09214948d' target=_blank style='color:#2F92EE;'>#中医药事业#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21494, encryptionId=9d09214948d, topicName=中医药事业)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=549e14938166, createdName=amy0555, createdTime=Fri Mar 09 10:45:00 CST 2018, time=2018-03-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1627066, encodeId=1ad2162e0665c, content=<a href='/topic/show?id=c9f65e45389' target=_blank style='color:#2F92EE;'>#政协委员#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=57453, encryptionId=c9f65e45389, topicName=政协委员)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bdbf21082352, createdName=dingxiaobo, createdTime=Fri Mar 09 10:45:00 CST 2018, time=2018-03-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=294016, encodeId=ab9f29401631, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/01/15/8213228fe923915543544ad3da7e1c64.jpg, createdBy=6bd82014262, createdName=秀红, createdTime=Thu Mar 08 05:56:26 CST 2018, time=2018-03-08, status=1, ipAttribution=)]
    2018-03-09 cathymary
  5. [GetPortalCommentsPageByObjectIdResponse(id=1796849, encodeId=bc161e96849c1, content=<a href='/topic/show?id=768121555ad' target=_blank style='color:#2F92EE;'>#中医药界政协委员#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21555, encryptionId=768121555ad, topicName=中医药界政协委员)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=44a360, createdName=jklm09, createdTime=Tue Oct 30 16:45:00 CST 2018, time=2018-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1978078, encodeId=298219e80780e, content=<a href='/topic/show?id=5bca258e611' target=_blank style='color:#2F92EE;'>#传承发展#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=25876, encryptionId=5bca258e611, topicName=传承发展)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dc7a157, createdName=jinweidong, createdTime=Wed Apr 18 09:45:00 CST 2018, time=2018-04-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1675574, encodeId=ccce16e557408, content=<a href='/topic/show?id=8e7d258696c' target=_blank style='color:#2F92EE;'>#传承#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=25869, encryptionId=8e7d258696c, topicName=传承)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=85d827261473, createdName=lishizhe, createdTime=Sat Aug 04 19:45:00 CST 2018, time=2018-08-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1409400, encodeId=87f9140940092, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Fri Mar 09 10:45:00 CST 2018, time=2018-03-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1557974, encodeId=12c6155e974fe, content=<a href='/topic/show?id=9d09214948d' target=_blank style='color:#2F92EE;'>#中医药事业#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21494, encryptionId=9d09214948d, topicName=中医药事业)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=549e14938166, createdName=amy0555, createdTime=Fri Mar 09 10:45:00 CST 2018, time=2018-03-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1627066, encodeId=1ad2162e0665c, content=<a href='/topic/show?id=c9f65e45389' target=_blank style='color:#2F92EE;'>#政协委员#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=57453, encryptionId=c9f65e45389, topicName=政协委员)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bdbf21082352, createdName=dingxiaobo, createdTime=Fri Mar 09 10:45:00 CST 2018, time=2018-03-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=294016, encodeId=ab9f29401631, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/01/15/8213228fe923915543544ad3da7e1c64.jpg, createdBy=6bd82014262, createdName=秀红, createdTime=Thu Mar 08 05:56:26 CST 2018, time=2018-03-08, status=1, ipAttribution=)]
  6. [GetPortalCommentsPageByObjectIdResponse(id=1796849, encodeId=bc161e96849c1, content=<a href='/topic/show?id=768121555ad' target=_blank style='color:#2F92EE;'>#中医药界政协委员#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21555, encryptionId=768121555ad, topicName=中医药界政协委员)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=44a360, createdName=jklm09, createdTime=Tue Oct 30 16:45:00 CST 2018, time=2018-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1978078, encodeId=298219e80780e, content=<a href='/topic/show?id=5bca258e611' target=_blank style='color:#2F92EE;'>#传承发展#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=25876, encryptionId=5bca258e611, topicName=传承发展)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dc7a157, createdName=jinweidong, createdTime=Wed Apr 18 09:45:00 CST 2018, time=2018-04-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1675574, encodeId=ccce16e557408, content=<a href='/topic/show?id=8e7d258696c' target=_blank style='color:#2F92EE;'>#传承#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=25869, encryptionId=8e7d258696c, topicName=传承)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=85d827261473, createdName=lishizhe, createdTime=Sat Aug 04 19:45:00 CST 2018, time=2018-08-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1409400, encodeId=87f9140940092, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Fri Mar 09 10:45:00 CST 2018, time=2018-03-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1557974, encodeId=12c6155e974fe, content=<a href='/topic/show?id=9d09214948d' target=_blank style='color:#2F92EE;'>#中医药事业#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21494, encryptionId=9d09214948d, topicName=中医药事业)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=549e14938166, createdName=amy0555, createdTime=Fri Mar 09 10:45:00 CST 2018, time=2018-03-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1627066, encodeId=1ad2162e0665c, content=<a href='/topic/show?id=c9f65e45389' target=_blank style='color:#2F92EE;'>#政协委员#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=57453, encryptionId=c9f65e45389, topicName=政协委员)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bdbf21082352, createdName=dingxiaobo, createdTime=Fri Mar 09 10:45:00 CST 2018, time=2018-03-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=294016, encodeId=ab9f29401631, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/01/15/8213228fe923915543544ad3da7e1c64.jpg, createdBy=6bd82014262, createdName=秀红, createdTime=Thu Mar 08 05:56:26 CST 2018, time=2018-03-08, status=1, ipAttribution=)]
  7. [GetPortalCommentsPageByObjectIdResponse(id=1796849, encodeId=bc161e96849c1, content=<a href='/topic/show?id=768121555ad' target=_blank style='color:#2F92EE;'>#中医药界政协委员#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21555, encryptionId=768121555ad, topicName=中医药界政协委员)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=44a360, createdName=jklm09, createdTime=Tue Oct 30 16:45:00 CST 2018, time=2018-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1978078, encodeId=298219e80780e, content=<a href='/topic/show?id=5bca258e611' target=_blank style='color:#2F92EE;'>#传承发展#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=25876, encryptionId=5bca258e611, topicName=传承发展)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dc7a157, createdName=jinweidong, createdTime=Wed Apr 18 09:45:00 CST 2018, time=2018-04-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1675574, encodeId=ccce16e557408, content=<a href='/topic/show?id=8e7d258696c' target=_blank style='color:#2F92EE;'>#传承#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=25869, encryptionId=8e7d258696c, topicName=传承)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=85d827261473, createdName=lishizhe, createdTime=Sat Aug 04 19:45:00 CST 2018, time=2018-08-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1409400, encodeId=87f9140940092, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Fri Mar 09 10:45:00 CST 2018, time=2018-03-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1557974, encodeId=12c6155e974fe, content=<a href='/topic/show?id=9d09214948d' target=_blank style='color:#2F92EE;'>#中医药事业#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21494, encryptionId=9d09214948d, topicName=中医药事业)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=549e14938166, createdName=amy0555, createdTime=Fri Mar 09 10:45:00 CST 2018, time=2018-03-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1627066, encodeId=1ad2162e0665c, content=<a href='/topic/show?id=c9f65e45389' target=_blank style='color:#2F92EE;'>#政协委员#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=57453, encryptionId=c9f65e45389, topicName=政协委员)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bdbf21082352, createdName=dingxiaobo, createdTime=Fri Mar 09 10:45:00 CST 2018, time=2018-03-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=294016, encodeId=ab9f29401631, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/01/15/8213228fe923915543544ad3da7e1c64.jpg, createdBy=6bd82014262, createdName=秀红, createdTime=Thu Mar 08 05:56:26 CST 2018, time=2018-03-08, status=1, ipAttribution=)]
    2018-03-08 秀红

    学习了

    0

Baidu
map
Baidu
map
Baidu
map